UGT2B Antibodies

Santa Cruz Biotechnology provides a broad selection of UGT2B monoclonal antibodies for research focused on understanding the UGT2B protein family. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UGT2B proteins play vital roles in metabolizing diverse endogenous and exogenous compounds, including hormones, drugs, and environmental toxins. The activity of UGT2B proteins maintains homeostasis and detoxifies potentially harmful substances in the body. Research has shown that altered UGT2B expression correlates with various diseases, highlighting its significance in therapeutic development and biomarker discovery. Understanding UGT2B protein function can lead to breakthroughs in drug metabolism research and toxicology studies. Investigating UGT2B proteins may reveal new therapeutic strategies for treating metabolic disorders. Characterization capabilities of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of UGT2B proteins and their impact on human health.